Paper1333367
Relationships between various uses of antineoplastic drug-interaction terms.
Wampler GL and 3 others. Cancer Chemother Pharmacol, 1992. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Relationships between various uses of antineoplastic drug-interaction terms. Papers, record 1333367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1333367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Drug Synergism | Major topic |
| Terminology as Topic | Major topic |
| Animals | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Carcinoma, Small Cell | |
| Cisplatin | |
| Etoposide | |
| Humans | |
| Leukemia P388 | |
| Lung Neoplasms | |
| Tumor Cells, Cultured |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 679196 | Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia. | Cancer Res | 1978 | https://conductscience.org/library/papers/679196 | PubMed |
| 2 | 6387058 | Relation of in vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma. | J Clin Oncol | 1984 | https://conductscience.org/library/papers/6387058 | PubMed |
| 3 | 476674 | An improved method for analyzing survival data from combination chemotherapy experiments. | Cancer Res | 1979 | https://conductscience.org/library/papers/476674 | PubMed |
| 4 | 3442730 | Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment. | Cancer Invest | 1987 | https://conductscience.org/library/papers/3442730 | PubMed |
| 5 | 6807534 | Drug activity and therapeutic synergism in cancer treatment. | Cancer Res | 1982 | https://conductscience.org/library/papers/6807534 | PubMed |
| 6 | 4771975 | Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia. | Acta Pathol Microbiol Scand A | 1973 | https://conductscience.org/library/papers/4771975 | PubMed |
| 7 | 2706626 | Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II). | Cancer Res | 1989 | https://conductscience.org/library/papers/2706626 | PubMed |
| 8 | 2593167 | Synergistic antitumor activity of etoposide and human interleukin-1 alpha against human melanoma cells. | J Natl Cancer Inst | 1989 | https://conductscience.org/library/papers/2593167 | PubMed |
| 9 | 3581096 | Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia. | Cancer Treat Rep | 1987 | https://conductscience.org/library/papers/3581096 | PubMed |
| 10 | 2386940 | Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. | Cancer Res | 1990 | https://conductscience.org/library/papers/2386940 | PubMed |
| 11 | 3038314 | In vitro chemosensitivity of human lung cancer cell lines. | Cancer Treat Rep | 1987 | https://conductscience.org/library/papers/3038314 | PubMed |
| 12 | 291480 | cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/291480 | PubMed |
| 13 | 422420 | Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. | Int J Radiat Oncol Biol Phys | 1979 | https://conductscience.org/library/papers/422420 | PubMed |
| 15 | 3607781 | Interaction of etoposide and cisplatin in an in vitro tumor model. | Cancer Treat Rep | 1987 | https://conductscience.org/library/papers/3607781 | PubMed |
| 16 | 7041539 | Criteria for analyzing interactions between biologically active agents. | Adv Cancer Res | 1981 | https://conductscience.org/library/papers/7041539 | PubMed |
| 17 | 6783143 | Survival analysis of drug combinations using a hazards model with time-dependent covariates. | Biometrics | 1980 | https://conductscience.org/library/papers/6783143 | PubMed |
| 18 | 3020696 | Cisplatin plus VP-16 in small-cell lung cancer. | Semin Oncol | 1986 | https://conductscience.org/library/papers/3020696 | PubMed |
| 19 | 2299590 | Isobolographic characterization of drug interactions incorporating biological variability. | J Pharmacol Exp Ther | 1990 | https://conductscience.org/library/papers/2299590 | PubMed |
| 20 | 7227366 | Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. | Eur J Biochem | 1981 | https://conductscience.org/library/papers/7227366 | PubMed |
| 21 | 3378962 | Synergy and antagonism are not synonymous with therapeutic advantage and disadvantage. | J Antimicrob Chemother | 1988 | https://conductscience.org/library/papers/3378962 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 12644815 | Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12644815 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1333367
GET https://conductscience.org/api/papers/v1/1333367/references?page=2